Barrie Levitt

1.9k total citations
65 papers, 1.4k citations indexed

About

Barrie Levitt is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Barrie Levitt has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Barrie Levitt's work include Cardiac electrophysiology and arrhythmias (22 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Arrhythmias and Treatments (7 papers). Barrie Levitt is often cited by papers focused on Cardiac electrophysiology and arrhythmias (22 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Arrhythmias and Treatments (7 papers). Barrie Levitt collaborates with scholars based in United States, Israel and Canada. Barrie Levitt's co-authors include Norman A. Cagin, Joel E. Richter, Jack Sherez, Shlomo Laniado, Gad Keren, Frank G. Standaert, C. Paul Bianchi, Jay Roberts, John C. Somberg and Arthur Raines and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Barrie Levitt

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barrie Levitt United States 20 842 262 247 215 152 65 1.4k
William Shapiro United States 25 1.2k 1.4× 404 1.5× 186 0.8× 173 0.8× 252 1.7× 69 1.9k
Peter E. Pool United States 26 1.7k 2.0× 305 1.2× 483 2.0× 297 1.4× 288 1.9× 57 2.5k
Dorothea McAreavey United States 23 1.2k 1.4× 282 1.1× 175 0.7× 194 0.9× 176 1.2× 57 1.8k
G. Schlierf Germany 15 681 0.8× 473 1.8× 219 0.9× 112 0.5× 186 1.2× 38 1.7k
Philip O. Ettinger United States 15 1.0k 1.2× 147 0.6× 191 0.8× 171 0.8× 171 1.1× 33 1.5k
Franz W. Amann Switzerland 23 905 1.1× 457 1.7× 179 0.7× 223 1.0× 240 1.6× 75 1.7k
W. J. Louis Australia 23 736 0.9× 252 1.0× 294 1.2× 102 0.5× 86 0.6× 54 1.7k
Richard S. Matteo United States 28 533 0.6× 705 2.7× 181 0.7× 197 0.9× 91 0.6× 122 2.1k
PA Poole-Wilson United Kingdom 19 1.8k 2.2× 226 0.9× 639 2.6× 353 1.6× 124 0.8× 50 2.6k
G Tognoni Italy 17 578 0.7× 177 0.7× 228 0.9× 60 0.3× 80 0.5× 49 1.3k

Countries citing papers authored by Barrie Levitt

Since Specialization
Citations

This map shows the geographic impact of Barrie Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barrie Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barrie Levitt more than expected).

Fields of papers citing papers by Barrie Levitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barrie Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barrie Levitt. The network helps show where Barrie Levitt may publish in the future.

Co-authorship network of co-authors of Barrie Levitt

This figure shows the co-authorship network connecting the top 25 collaborators of Barrie Levitt. A scholar is included among the top collaborators of Barrie Levitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barrie Levitt. Barrie Levitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levitt, J., et al.. (2010). The Sensitivity and Specificity of Potassium Hydroxide Smear and Fungal Culture Relative to Clinical Assessment in the Evaluation of Tinea Pedis: A Pooled Analysis. Dermatology Research and Practice. 2010(1). 764843–764843. 41 indexed citations
2.
Levitt, Barrie & Joel E. Richter. (2007). Dysphagia lusoria: a comprehensive review. Diseases of the Esophagus. 20(6). 455–460. 101 indexed citations
3.
Yacobi, Avraham, Eric Masson, Derek Ganes, et al.. (2000). Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin. The Journal of Clinical Pharmacology. 40(8). 826–835. 14 indexed citations
4.
Yacobi, Avraham, Steve Zlotnick, John L. Colaizzi, et al.. (1999). A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: A case for carbamazepine. Clinical Pharmacology & Therapeutics. 65(4). 389–394. 12 indexed citations
5.
Bialer, Meir, Lidia Arcavi, Andrew Volosov, et al.. (1998). Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine. Epilepsy Research. 32(3). 371–378. 18 indexed citations
6.
Bialer, Meir, et al.. (1998). Criteria to Assess In Vivo Performance and Bioequivalence of Generic Controlled‐Release Formulations of Carbamazepine. Epilepsia. 39(5). 513–519. 19 indexed citations
7.
LeJemtel, Thierry H., et al.. (1989). Effects of phosphodiesterase inhibition on skeletal muscle vasculature. The American Journal of Cardiology. 63(2). A27–A30. 17 indexed citations
8.
Somberg, John C., Deborah Keefe, & Barrie Levitt. (1985). Digitalis: Its Place in Therapy. The Journal of Clinical Pharmacology. 25(7). 555–559. 2 indexed citations
9.
Levitt, Barrie & Deborah Keefe. (1985). Clinical Use of Digitalis Materials. The Journal of Clinical Pharmacology. 25(7). 507–513. 3 indexed citations
10.
Cagin, Norman A., et al.. (1978). Blockade of tissue uptake of the antineoplastic agent, doxorubicin.. Journal of Pharmacology and Experimental Therapeutics. 204(1). 226–229. 11 indexed citations
11.
Levitt, Barrie, et al.. (1977). A comparison of actodigin and ouabain in cats.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 226(2). 263–9. 5 indexed citations
12.
Se, Epstein, et al.. (1976). Protection of ischemic myocardium by nitroglycerin: experimental and clinical results.. PubMed. 53(3 Suppl). I191–8. 23 indexed citations
13.
Borer, Jeffrey, David R. Redwood, Barrie Levitt, et al.. (1975). Reduction in Myocardial Ischemia with Nitroglycerin or Nitroglycerin plus Phenylephrine Administered during Acute Myocardial Infarction. New England Journal of Medicine. 293(20). 1008–1012. 122 indexed citations
14.
Levitt, Barrie, et al.. (1973). ALTERATION OF THE EFFECTS AND DISTRIBUTION OF OUABAIN BY SPINAL CORD TRANSECTION IN THE CAT. Journal of Pharmacology and Experimental Therapeutics. 185(1). 24–28. 23 indexed citations
15.
Cagin, Norman A., et al.. (1973). Bifascicular block: A clinical and electrophysiologic study. American Heart Journal. 86(2). 173–181. 24 indexed citations
16.
Raines, Arthur, Yung J. Sohn, & Barrie Levitt. (1971). SPINAL EXCITATORY AND DEPRESSANT EFFECTS OF SODIUM DIPHENYLTHIOHYDANTOINATE. Journal of Pharmacology and Experimental Therapeutics. 177(2). 350–359. 8 indexed citations
17.
Levitt, Barrie, et al.. (1968). SLEEP REGIMEN FOR MYOCARDIAL INFARCTION. The Lancet. 291(7555). 1308–1309. 2 indexed citations
18.
Levitt, Barrie, et al.. (1966). SOME ASPECTS OF THE ANTI‐ARRHYTHMIC ACTIVITY OF RESERPINE*. British Journal of Pharmacology and Chemotherapy. 28(1). 44–50. 17 indexed citations
19.
Standaert, Frank G., Barrie Levitt, & Jay Roberts. (1966). Antagonism of Digitalis Arrhythmia by Pronethalol : a Neural Phenomenon?. Nature. 210(5037). 742–744. 11 indexed citations
20.
Levitt, Barrie, et al.. (1963). Free perforation in regional enteritis. Digestive Diseases and Sciences. 8(8). 678–681. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Shapiro Breakdown of academic impact, for papers by Peter E. Pool Breakdown of academic impact, for papers by Dorothea McAreavey Breakdown of academic impact, for papers by G. Schlierf Breakdown of academic impact, for papers by Philip O. Ettinger Breakdown of academic impact, for papers by Franz W. Amann Breakdown of academic impact, for papers by W. J. Louis Breakdown of academic impact, for papers by Richard S. Matteo Breakdown of academic impact, for papers by PA Poole-Wilson Breakdown of academic impact, for papers by G Tognoni
Rankless by CCL
2026